From gene knockout studies in mice, it has been deduced that MMP-9 inhibition may be useful in chronic organ-specific auto-immune diseases such as multiple sclerosis [17], diabetes [18] and rheumatoid arthritis [19], whereas the use of MMP-9 inhibitors needs to be questioned for the treatment of systemic auto-immune diseases [20]. The gene discussed is MMP9; the disease is diabetes mellitus.